OCULAR ADVERSE EFFECTS Evidence based on recent studies While GLP-1 RAs have demonstrated potent glucose-lowering effects, their impact on diabetic retinopathy remains incompletely elucidated
Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment
With a US presence spanning 40 years, Novo Nordisk US is headquartered in New Jersey and employs approximately 10,000 people throughout the country across more than 10 manufacturing, R&D, and corporate locations in seven states plus Washington, DC
At this time, more research is needed to understand how GLP-1 medications may affect milk supply long term
Every members care plan involves Medication, Mindset, and Lifestyle
All animal studies were approved by the State of Bavaria, Germany, or the Insitutional Animal Care and Use Committee of the University of Cincinnati, OH, USA and conducted on the basis of the underlying animal welfare law of the respective countries
